Purchase Order HHSN272201601043P

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...

This federal contract award, HHSN272201500396P, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Alpha Diagnostic International Inc. for the provision of an "AMBIS NO. 1725132REAGENT - EBOLA VIRUS NP IGG ELISA KIT, QUANTITATIVE" with a ceiling value of $151,462.50. The contract is a firm-fixed-price purchase order with a completion date of March 26, 2015. Alpha Diagnostic International Inc. is a...

This is a Federal contract award to Mybiosource Inc., a minority-owned, woman-owned, and Asian-Pacific American-owned small business, for the provision of ELISA (Enzyme-Linked Immunosorbent Assay) kits. The contract, valued at $6,594.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, on August 1, 2017, with a completion date of September 15, 2017. The contract is a Firm Fixed Price Purchase Order. This award is likely part of NIAID's...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the delivery of an AMBIS #1743202 kit, which includes human anti-Zaire Ebola virus nucleoprotein (NP) IgG ELISA kits, 96 tests, and a low NSB diluent bottle. The contract has a firm fixed price of $5,544.50 and a completion date of June 16, 2016. The contract was...

This federal contract award, valued at $8,300.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the prime contractor Proteinsimple, a subsidiary of Bio-Techne Corporation. The contract is for the delivery of the AlphaLISA Mini Analysis System, a specialized protein analysis instrument. The contract was awarded on a firm fixed-price basis without the use of any set-aside designations. Through this contract, Proteinsimple will provide the NIAID with the...

<p>This is a Firm Fixed Price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to The Madrillon Group Inc., a woman-owned small business. The contract has a ceiling value of $59,906.30 and was awarded on September 2, 2014, with a performance period ending on April 23, 2016. The contract is for NIAID evaluation services and does not have a set-aside designation.</p>

This federal contract award, identified as HHSN272201500269P, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Proteinlinks Inc., a minority-owned, for-profit, and woman-owned business. The $8,010.00 firm fixed price contract is for &quot;PROTEIN LINKS HYBRID SCREENING&quot; services, with a performance period ending on January 13, 2015. The contract has no set-aside designation and is not associated with a larger...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A &amp; A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A &amp; A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...

<p>This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Madrillon Group Inc, a woman-owned small business. The contract has a firm fixed price of $220,894.30 and a completion date of September 30, 2016. The contract is for NIAID Evaluation Services and does not have a set-aside designation. No additional details about the specific products or services being delivered are provided.</p>

<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the provision of 96-test kits for a Human Anti-Zaire-Ebola Virus Glycoprotein (GP) IgG ELISA. The contract has a ceiling value of $146,525.00 and a period of performance ending on April 1, 2015. This contract does not have a set-aside designation.</p>